Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

TAKTAK
29 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in TAKEDA PHARMACEUTICAL CO LTD

NORTHERN TRUST CORP holds 2M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $36.3M as of 2026-Q1. The position was increased (+15.4% shares). TAK represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$36.3M

Current Shares

2M

Total Value Change

-$49.6M

Total Shares Change

-2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2M
+15.4%
$36.3M0.0%$18.08
33
2025-Q4
Decreased
1.7M
-6.8%
$26.5M0.0%$15.63
0
2025-Q3
Decreased
1.8M
-10.2%
$26.7M0.0%$14.62
0
2025-Q2
Increased
2M
+23.8%
$31.4M0.0%$15.10
35
2025-Q1
Decreased
1.6M
-12.5%
$24.4M0.0%$14.71
0
2024-Q4
Increased
1.9M
+14.6%
$24.8M0.0%$12.87
33
2024-Q3
Increased
1.6M
+2.8%
$23.3M0.0%$13.89
29
2024-Q2
Decreased
1.6M
-14.8%
$20.6M0.0%$12.36
0
2024-Q1
Increased
1.9M
+2.9%
$25.9M0.0%$13.27
29
2023-Q4
Decreased
1.8M
-17.2%
$25.9M0.0%$13.36
0
2023-Q3
Decreased
2.2M
-3.7%
$33.9M0.0%$14.48
0
2023-Q2
Decreased
2.3M
-0.0%
$35.7M0.0%$14.70
0
2023-Q1
Decreased
2.3M
-4.4%
$37.5M0.0%$15.31
0
2022-Q4
Increased
2.4M
+8.6%
$37.1M0.0%$14.60
32
2022-Q3
Decreased
2.2M
-3.0%
$28.4M0.0%$12.14
0
2022-Q2
Increased
2.3M
+1.8%
$31.7M0.0%$12.97
29
2022-Q1
Decreased
2.2M
-5.2%
$31.8M0.0%$13.51
0
2021-Q4
Increased
2.3M
+3.4%
$31.9M0.0%$12.71
30
2021-Q3
Decreased
2.3M
-46.5%
$37.1M0.0%$15.27
0
2021-Q2
Decreased
4.2M
-7.1%
$71.3M0.0%$15.76
0
2021-Q1
Increased
4.6M
+4.1%
$83.2M0.0%$17.18
31
2020-Q4
Increased
4.4M
+3.1%
$79.7M0.0%$17.02
31
2020-Q3
Increased
4.2M
+11.3%
$75.8M0.0%$16.98
33
2020-Q2
Increased
3.8M
+11.8%
$68.4M0.0%$16.95
33
2020-Q1
Decreased
3.4M
-8.9%
$51.8M0.0%$14.63
0
2019-Q4
Decreased
3.7M
-4.3%
$73.9M0.0%$18.41
0
2019-Q3
Decreased
3.9M
-3.6%
$67.4M0.0%$16.23
0
2019-Q2
Decreased
4.1M
-3.7%
$71.9M0.0%$16.57
0
2019-Q1
New
4.2M
-
$85.9M0.0%$19.07
41

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used